| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |